Edesa Biotech, Inc. (Nasdaq: EDSA) is a clinical-stage biopharmaceutical company developing innovative ways to treat inflammatory and immune-related diseases. Our most advanced drug candidate is EB05 (paridiprubart), a monoclonal antibody developed for acute and chronic disease indications that involve dysregulated innate immune responses. Edesa is currently evaluating EB05 in a Phase 3 study as a potential treatment for Acute Respiratory Distress Syndrome (ARDS), a life-threatening form of respiratory failure. In addition, Edesa is developing an sPLA2 inhibitor, EB01, as a topical treatment for chronic Allergic Contact Dermatitis (ACD), a common occupational skin condition. The company has also received regulatory approval to conduct a Phase 2 trial its EB06 monoclonal antibody as a treatment for vitiligo, a life-altering autoimmune disease that causes skin to lose its color in patches. We also are planning a future Phase 2 study of paridiprubart for systemic sclerosis (scleroderma), an autoimmune rheumatic disorder that causes fibrosis (scarring/hardening) of skin and internal organs.
Company Details
- Employees
- 22
- Founded
- 2015
- Address
- 100 Spy Court, Markham,on L3r 5h6,canada
- Phone
- (905)-475 1234
- in****@****ech.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- edesabiotech.com
- Keywords
- Dermatology, Contact Dermatitis, Gastrointestinal, biotechnology, autoimmune, inflammatory, covid, ARDS, vitiligo, scleroderma, systemic sclerosis.
- HQ
- Markham, ON
Edesa Biotech, Inc. Questions
Edesa Biotech, Inc.'s helpline number is (905)-475 1234
Edesa Biotech, Inc.'s website is edesabiotech.com
Edesa Biotech, Inc.'s LinkedIn profile is https://ca.linkedin.com/company/edesa-biotech
Edesa Biotech, Inc. has
22 employees.
View email and phone details for 22
employees at Edesa Biotech, Inc..
Edesa Biotech, Inc.'s industry is
Biotechnology Research
Edesa Biotech, Inc.'s top competitors are
Cipher Pharmaceuticals Inc. (Tsx: Cph) (Otcqx:cphrf),
Arch Biopartners Inc (Arch:tsxv) (Achff:otcqb),
Iconthin Biotech,
Ax Pharmaceutical Corp,
Abcuro, Inc,
Pharmala Biotech Inc. (Mdma.cse),
Exzell Pharma,
Newleos Therapeutics,
Apotex Inc.,
Virica Biotech.
Edesa Biotech, Inc.'s support email address is info@edesabiotech.com
Edesa Biotech, Inc.'s categories are Biotechnology Research
Edesa Biotech, Inc.'s founding year is 2015
